Prous Science
Prous Science is an international health science publishing company, established in 1958 and headquartered in Barcelona, Spain.
Its head offices are located in Barcelona and it has subsidiaries in Philadelphia (USA), Buenos Aires (Argentina) and Tokyo (Japan). Prous employs 500 people worldwide, which include prestigious international opinion leaders in diverse disciplines of medical sciences.
Its research is based on the use of datamining, statistical analysis and chemoinformatic techniques, a recent and innovative international concept registered under the name "druginformatics". These techniques are complemented by laboratory methods from combinatorial chemistry, molecular biology and functional genomics.

This is an excerpt from the article Prous Science from the Wikipedia free encyclopedia. A list of authors is available at Wikipedia.
The article Prous Science at en.wikipedia.org was accessed 92 times in the last 30 days. (as of: 07/08/2013)
Images on Prous Science
Preview image:
Original:
Search results from Google and Bing
1
>30
1
Prous Science
DYNAMIC, RELEVANT DRUG NEWS AND EMAIL ALERTS POSTED EVERY BUSINESS DAY. Every business day, Thomson Reuters Drug News selects the ...
www.prous.com/
2
>30
2
Prous Science - Wikipedia, the free encyclopedia
Prous Science is an international health science publishing company, established in 1958 and headquartered in Barcelona, Spain. Its head offices are located ...
en.wikipedia.org/wiki/Prous_Science
3
>30
3
Thomson Reuters Integrity
... Integrity is available to licensed users. To request more information about this product, click here. © 2013 Prous Science. All rights reserved. Legal Information.
integrity.thomson-pharma.com/
4
>30
4
Prous Science | LinkedIn
Welcome to the company profile of Prous Science on LinkedIn.
www.linkedin.com/company/prous-science
5
>30
5
Thomson Acquires Prous Science - Investor Relations - Thomson ...
Sep 27, 2007 ... Its well-known Prous Science Integrity(R) portal provides access to more than 265,000 compounds with demonstrated biological activity and ...
ir.thomsonreuters.com/phoenix.zhtml?c=76540&p=irol-newsArticle&ID=1056155&highlight=
6
>30
6
"Prous Science Drugs of the Future"[sourcename] - PubChem ...
HBF-0079 Source: Prous Science Drugs of the Future (762068) SID: 136350129 CID: 746607 2. LCH-7749944 Source: Prous Science Drugs of the Future ...
www.ncbi.nlm.nih.gov/pcsubstance?term=%22Prous+Science+Drugs+of+the+Future%22%5Bsourcename%5D&cmd=search&db=pcsubstance
7
>30
7
Prous Science S.A.U.: Private Company Information - Businessweek
Prous Science S.A.U. company research & investing information. Find executives and the latest company news.
investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=37412798
8
>30
8
PROUS SCIENCE DRUG DATA REPORT [452]
The Prous Science Drug Data Report database provides continuously updated information on more than 65000 bioactive compounds reported in the print ...
library.dialog.com/bluesheets/html/bl0452.html
9
>30
9
Prous Science Drug Data Report - Dialog
Oct 8, 2012 ... Subject Coverage. Prous Science Drug Data Report tracks thousands of bioactive compounds from the patent stage through to marketing. The.
www.dialog.com/prosheets/prous_science_drug_data_report.pdf
10
>30
10
Thomson acquires Prous Science - Research Information
Oct 1, 2007 ... Thomson has acquired Prous Science. Prous Science's information solutions help knowledge-based drug discovery and development.
www.researchinformation.info/news/news_story.php?news_id=135
Search results for "Prous Science"
Google: approx. 123.000
Prous Science in science
Summary - Journals on the Web - Prous Science
Prous.com ... Speakers included representatives from Novartis AG, the University of Nottingham, the University of Newcastle, Bart's and ... 2002 Prous Science.
Data Source Search | Prous Science Drugs of the Future
Prous Science Drugs of the Future. ... Caddick Group, University College London ... DISMA, Department of Agri-Food Molecular Sciences, University of Milano, ...
PROUS SCIENCE DRUG NEWS & PERSPECTIVES [455]
The Prous Science Drug News & Perspectives database, produced by Prous Science Publishers, allows ... The phase I/II will be conducted at the University of.
AAA Chemistry ABBLIS Chemicals Abbott Labs ABI Chem AbMole ...
... EDASA Scientific Compounds June 2013 EMD Biosciences Emory University ... murugesh, palaniswamy ProbeDB ProtChemDB Prous Science Drugs of the ...
Prous Science - The University of Melbourne
Prous Science uri icon. ©2013 The University of Melbourne | Terms of Use ... The University of Melbourne Parkville 3010 VIC Australia. Email: Make an enquiry.
EFMC Prous Science Award
Prous Institute - Overton and Meyer Award for New Technologies in Drug Discovery ... Karl-Franzens University, Graz, on the basis of his outstanding scientific ...
European Federation of Medicinal Chemistry Prous Science Award
Winner of the 2006 Prous Science Award for New Technologies in Drug Discovery ... Karl-Franzens University, Graz, on the basis of his outstanding scientific ...
Prous Science - HighBeam Business
News and information about Prous Science. Drug Week. Studies from Griffith University Add New Findings in the Area of Drug Development Drug Week; June ...
Marisa Guardiola - Prous Science, CSIC... - Yatedo
Marisa Guardiola, Selection and analysis of scientific publications (patents...Prous Science, CSIC, University of Utah, CSIC.
NUIT Partnerships - Northwestern University Information Technology
Dec 12, 2011 ... Northwestern University Information Technology Home .... University of Washington; Prous Science; PurdueWave—Advanced optical network ...
Books on the term Prous Science
Living-donor liver transplantation: surgical techniques and ...
Living-donor liver transplantation: surgical techniques and ...
Koichi Tanaka, Koichi Tanaka, Yukihiro Inomata, Satoshi Kaihara, 2003
surgical techniques and innovations Koichi Tanaka, Koichi Tanaka, Yukihiro Inomata, Satoshi Kaihara. a much better chance for the grafted liver to secure the portal blood flow. In metabolic liver disease, the portal vein to the remnant liver is  ...
Pharmacophore: Perception, Development, and Use in Drug Design
Pharmacophore: Perception, Development, and Use in Drug Design
Osman F. Güner, 2000
Barcelona: Prous Science, 1994:246-251. 2. Barnum D, Greene J, Smellie A, Sprague P: Identification of common functional configurations among molecules. J Chem InfCompu Sci 1996, 36:563-571. 3. Martin YC, Bures MG, Danaher EA, ...
Development of Google searches


Blog posts on the term
Prous Science
Manuals: Pharmacokinetic Study Of Theophylline In Dogs - Prous Science, Free Download Dell Optiplex G1, Dell Optiplex G1 User Manuals, Download Dell Optiplex G1 User Guides - DNDownloads
Manuals : Pharmacokinetic Study Of Theophylline In Dogs - Prous Science dell optiplex g1, (OptiPlex G1, Dell Computer Corp., Round Rock, TX,. USA) was used for each analysis. RESULTS. Comparison study of theophylline and aminophylline . dell optiplex g1 user manuals, dell optiplex g1 guides, dell optiplex g1 ebooks, dell optiplex g1 pdf file, dell optiplex g1, download dell optiplex g1 user guides, dell optiplex g1 manuals, free download dell optiplex g1
www.dndownloads.com/pharmacokinetic-study-of-theophylline-in-dogs-prous-science/
Canadian Thompson Corporation Acquires Spanish Prous Science at Business Incorporation House
Canadian Thompson Corporation Acquires Spanish Prous Science by Don Gould ]]>.
business-house.net/canadian-thompson-corporation-acquires-spanish-prous-science/
mesothelioma: drug treatment and other interventions Prous Science – Mesothelioma Help
Multimodality Therapy . Malignant pleural disease has been suggested to be an ideal model for testing new ... 93 Out of 100 by 180 users
www.mesotheliomahelpstore.com/mesothelioma-help/mesothelioma-drug-treatment-and-other-interventions-prous-science.html
mesothelomia: mesothelioma: drug treatment and other interventions Prous Science
www.thedialog.ca/mesothelioma-drug-treatment-and-other-interventions-prous-science/
SIGA Technologies' ST-246 Named 'Molecule of the Month' by Prous Science Nasdaq:SIGA
NEW YORK, Oct. 15, 2008 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, today announced that Prous Science, a division of Thomson Reuters, has recognized ST-246, SIGA's smallpox antiviral, as "Molecule of the Month" for its distinctiveness and achievements. SIGA developed tecovirimat, the generic scientific name for the active ingredient in ST-246, largely because the Government has declared the smallpox pathogen to be a "Category A" virus presenting a substantial bio-warfare threat.
www.globenewswire.com/news/viewbygnw?id=152243
Entrepreneurs Forum in Barcelona – Dr. Josep Prous – Founder of Prous Institute and Prous Science | Rafael del Pino Alumni Association
On Monday November 30th, the Rafael del Pino Alumni Association, with the support of the Rafael del Pino Foundation, was pleased to organize a dinner-colloquium
www.bfrdelpino.org/en/rafael-del-pino/entrepreneurs-forum-in-barcelona-%E2%80%93-dr-josep-prous-%E2%80%93-founder-of-prous-institute-and-prous-science/
ニュースリリースのリリースコンテナ第二倉庫 Thomson Acquires Prous Science
ニュースサイトなど宛てに広く配信された、ニュースリリース(プレスリリース)、 開示情報、IPO企業情報の備忘録。 大手サイトが順次削除するリリースバックナンバーも、蓄積・無料公開していきます。 ※リリース文中の固有名詞は、発表社等の商標、登録商標です。 ※リリース文はニュースサイト等マスコミ向けに広く公開されたものですが、著作権は発表社に帰属しています。
overturekeyword.blog.shinobi.jp/%E6%9C%AA%E9%81%B8%E6%8A%9E/thomson%20acquires%20prous%20science%20
Thomson Acquires Prous Science | PressReleasePoint
www.pressreleasepoint.com/thomson-acquires-prous-science-0
Science Abstracts: Prous Science acquired by Thomson scientific
Prous Science has been acquired by Thomson Scientific,based in Toronto. Prous Science,based in Barcelona ,Spain markets 265,000 compounds to scientists.
scienceabstracts.blogspot.com/2007/09/prous-science-acquired-by-thomson.html
Thomson Reuters Launches New Developments To Support Synthetic Chemists
Thomson Reuters today announced the newest release of Prous Science Integrity(R) developed in response to demand from synthetic chemists in...
www.chemicalonline.com/doc/Thomson-Reuters-Launches-New-Developments-To-0001?atc~c=771+s=773+r=001+l=a
123